Jonathan Arnold is Vice President, Head of Oncology and Precision Diagnostics at QIAGEN – a company that serves more than 500,000 customers around the globe. QIAGEN helps these customers unlock answers from the building blocks of life – DNA, RNA. QIAGEN enables these customer to make improvements in life by delivering Sample to Insight solutions for molecular testing. He also is Vice President, Head of Molecular Diagnostics Marketing since 2019. Mr. Arnold is responsible for QIAGEN’s MDx oncology and companion diagnostic business that manages all the companion diagnostic and molecular diagnostic products across oncology including multiple technology platforms (e.g. NGS, qPCR, pyrosequencing technologies).
Jonathan Arnold has been a part of QIAGEN for more than six years, starting as Head of NGS Marketing and Product Management. He has held various senior positions during his tenure including serving as the Oncology Franchise Business Lead (March 2016 – January 2017) and Vice President, Head of Partnering for Precision Diagnostics (January 2017 – January 2018). Before joining QIAGEN, he held various leadership positions in the field of diagnostics and healthcare for several leading companies including Visible Genetics Inc., Bayer Healthcare and Siemens).
Currently, Mr. Arnold is a Member of World Economic Forum (WEF) Precision Medicine Council and has served on the Board of various companies including acting as a strategic advisor to Therawis Diagnostics GmbH
Jonathan graduated with a Bachelor of Science, Biology from Missouri State University Springfield, Missouri Additionally, he holds Master degree in Management (University of Florida, Gainesville, Florida) and Master degree in Molecular Genetics and Microbiology (University of Florida, Gainesville, Florida).
